Applied Filters
Roche unit wins Fed Circ clash over blood clot treatment
Long-running legal dispute tackles questions of enablement and ‘undue experimentation’ | Federal Circuit says it is bound by SCOTUS’ findings in Amgen v Sanofi.
Natera files patent lawsuit over DNA technology
The lawsuit alleged the unlawful use of cfDNA technology in RaDaR assay and related products | Adds to an existing legal action the company filed against Inivata.
US court resolves muscle relaxant dispute by enforcing arbitration award
Polpharma’s injunction bid fails as motion is dismissed with prejudice | Court upholds Swiss Arbitration process.
Medtronic faces patent review revival as Fed Cir faults PTAB
Precedential decision marks blow for medical device maker after earlier win | PTAB criticised for “fundamental legal error” and “narrow definition”.
Dechert hires Harvard-educated chemist as IP partner
John Rearick is the latest addition to the firm to strengthen its life sciences practice.
FTC wades into Medtronic bipolar energy case
Commission says that medical device maker’s arguments have broad implications for antitrust enforcement | Dispute concerns alleged exclusive-dealing and bundling arrangements.
FTC weighs in on AbbVie antitrust litigation
Commission argues that a New York federal court erred in its finding that deals between an AbbVie unit and generic manufacturers were justified | US Supreme Court previously ruled that “unjustified” reverse payments can violate the antitrust laws.
Bausch targets Israeli firm in skin treatment dispute
Pharma company claims infringement of both patents that cover the blockbuster treatment | Generic version has been in motion since May last year.
AbbVie unit sues Chinese rival over blood cancer drug
Both drug treatments inhibit a protein called Bruton’s tyrosine kinase that can trigger cancer | Lawsuit comes in wake of patent grant for disputed drug | New study caused headaches for AbbVie’s subsidiary.
